Popular terms

Elastin topics
Mometasone Furoate
Medical Device
Polypeptide
Azelastine
Antibodies
Aortic Aneurysm
Polyclonal
Sample Preparation
Control Group
Refractory
Spectrometry
Internal Standard
Elastic Fiber
Chronic Obstructive Pulmonary Disease
Chronic Bronchitis

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Elastin patents



      

This page is updated frequently with new Elastin-related patent applications.




Date/App# patent app List of recent Elastin-related patents
07/07/16
20160194379 
 Regeneration of damaged tissue patent thumbnailRegeneration of damaged tissue
A method of healing a wound including contacting a wound edge with a tropoelastin or elastin derived peptide in conditions for enabling a sustained contact of the tropoelastin with the wound edge for a time period for enabling re-epithelialization of the wound.. .
Elastagen Pty Ltd


06/30/16
20160185737 
 N-alkoxyamide conjugates as imaging agents patent thumbnailN-alkoxyamide conjugates as imaging agents
The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided.

06/30/16
20160184177 
 Systems and methods for regulation of one or more epidermal or dermoepidermal proteins patent thumbnailSystems and methods for regulation of one or more epidermal or dermoepidermal proteins
The disclosed embodiments provide skin stimulating devices and methods that address the aging effects of skin at a protein level. Particularly, cyclical mechanical strain is used to regulate specific proteins within the skin, so as to produce specific effects.

06/30/16
20160184176 
 Systems and methods for regulation of one or more cutaneous proteins patent thumbnailSystems and methods for regulation of one or more cutaneous proteins
The disclosed embodiments provide skin stimulating devices and methods that address the aging effects of skin at a protein level. Particularly, cyclical mechanical strain is used to regulate specific proteins within the skin, so as to produce specific effects.

06/30/16
20160184175 
 Systems and methods for regulation of one or more epidermal proteins patent thumbnailSystems and methods for regulation of one or more epidermal proteins
The disclosed embodiments provide skin stimulating devices and methods that address the aging effects of skin at a protein level. Particularly, cyclical mechanical strain is used to regulate specific proteins within the skin, so as to produce specific effects.

06/23/16
20160176949 
 Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer patent thumbnailSilk-elastin like protein polymers for embolization and chemoembolization to treat cancer
A chemoembolic agent is disclosed that includes an injectable, recombinantly synthesized silk-elastin like protein copolymer and one or more chemotherapeutic agents. Upon injection, the chemoembolic agent blocks the tumor vasculature, including the capillary bed, and may optionally release chemotherapeutic agents.

06/23/16
20160175280 
 Composition for promoting collagen production, for promoting elastin production and/or for promoting keratinocyte migration and usage therefor patent thumbnailComposition for promoting collagen production, for promoting elastin production and/or for promoting keratinocyte migration and usage therefor
The present invention relates to a composition for enhancing collagen production, for enhancing elastin production and/or for enhancing keratinocyte migration, including sesaminol as an active component. The present invention also relates to a method for enhancing collagen production, for enhancing elastin production and/or for enhancing keratinocyte migration, including administering the composition..

06/16/16
20160168228 
 Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides patent thumbnailGeneration of hemoglobin-based oxygen carriers using elastin-like polypeptides
Described herein is the use of elastin-like polypeptides to generate hemoglobin-based oxygen carriers as a means of preventing and treating conditions caused by blood loss or anemia, for example, hemorrhagic shock. Elastin-like polypeptides are capable of creating therapeutically functional fusion proteins through genetic engineering with a therapeutic agent, for example, hemoglobin and biologic equivalent thereof.
S-aima Holding Company, Llc


06/16/16
20160166737 
 Collagen sponge patent thumbnailCollagen sponge
A resilient resorbable chemically crosslinked collagen sponge for promoting soft tissue volume augmentation in the oral region, comprising 60-96% (w/w) collagen and 4-40% (w/w) elastin, which shows by mercury intrusion porosimetry interconnected pores with a median pore diameter between 50 and 90 μm and at least 80% porosity with a pore diameter more than 10 μm, an onset temperature of 45 to 57° c. And a density in dry state from 50 to 65 mg/cm3.
Geistlich Pharma Ag


05/26/16
20160143726 
 Process for preparing tissue regeneration matrix patent thumbnailProcess for preparing tissue regeneration matrix
The present invention is directed to a process for making a tissue regeneration matrix. The process comprises providing a collagen-glycosaminoglycan-tropoelastin dispersion; freeze-drying the dispersion to provide a porous freeze-dried matrix; and then crosslinking the porous freeze-dried matrix.
Integra Lifesciences Corporation


05/19/16
20160136109 

Compositions for tissue stabilization


Collagen crosslinking/stabilization composition optionally in combination with elastin crosslinking composition as treatment of vascular aneurysms, methods of using the compositions, especially with respect to in vivo procedures are described. The treatment is achieved through the delivery of an effective amount of crosslinking/stabilization composition to the site of the aneurysm.
Vatrix Medical, Inc.


05/12/16
20160129045 

Composition for wound-healing comprising adult stem cells and elastin-like polypeptides


Provided is a composition for wound-healing containing adult stem cells and elastin-like polypeptides, and more specifically, to a composition for wound-healing capable of effectively treating skin wounds by simultaneously administering elastin-like polypeptides along with adult stem cells thereby increasing the viability of the adult stem cells transplanted on the wounds and promoting angiogenesis.. .
Daegu Gyeongbuk Institute Of Science And Technology


05/05/16
20160120952 

Therapeutic agents comprising elastin-like peptides


The present invention provides therapeutic agents and compositions comprising elastin-like peptides (elps) and therapeutic proteins. In some embodiments, the therapeutic protein is a glp-1 receptor agonist, insulin, or factor vii/viia, including functional analogs.
Duke University


04/28/16
20160114053 

Methods and compositions for delivering active agents with enhanced pharmacological properties


Provided herein are methods of enhancing in vivo efficacy of an active agent, comprising: administering to a subject an active agent that is coupled to a bioelastic polymer or elastin-like peptide, wherein the in vivo efficacy of the active agent is enhanced as compared to the same active agent when administered to the subject not coupled to (or not associated with) a bioelastic polymer or elp.. .
Duke University


03/31/16
20160091502 

Fibrosis biomarker assay


Methods of diagnosis or of quantitation of fibrosis are provided that comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a biofluid sample, and associating an elevation of the measure in the patient above a normal level with the presence or extent of fibrosis. The immunoassay is conducted by a contacting protein fragments naturally present in the sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to the immunological binding partner to measure therein protein fragments comprising the neo-epitope.
Nordic Bioscience A/s


03/31/16
20160089415 

Elastin protective polyphenolics and methods of using the same


Dermal fibroblasts permanently loose their ability to synthesize elastin, the major component of elastic fibers, shortly after puberty. This progressive loss of elastic fibers cannot be replaced, resulting in the physical signs of aging.
Human Matrix Sciences, Llc


03/10/16
20160067741 

Scalable three-dimensional elastic construct manufacturing


The present invention relates to tropoelastin and to tissue repair and restoration using elastic materials. Disclosed is a process for producing an elastic material from tropoelastin including heating a solution of tropoelastin to form an elastic material from the tropoelastin in the solution.
Elastagen Pty Ltd.


02/25/16
20160051722 

Mesenchymal stem cell-hydrogel-biodegradable or mesenchymal stem cell-hydrogel-undegradable support composition for skin regeneration or wound healing


The present invention relates to a composition comprising mesenchymal stem cell-hydrogel-biodegradable support or mesenchymal stem cell-hydrogel-undegradable support, a sheet comprising the composition and a method for the preparation thereof. By using the sheet comprising the adipose-derived mesenchymal stem cell-hydrogel biodegradable or undegradable support, stem cells of high activity may be applied directly to the wound without isolation process using protease.
Anterogen Co., Ltd.


02/25/16
20160051642 

Treatment of peyronie's disease


The invention relates to systems and therapeutic methods to reduce plaque causing peyronie's disease. One approach uses high pressure injection of collagenase-containing composition into a penile plaque.
Ams Research, Llc


02/18/16
20160045415 

Elastin synthesis/regeneration promoting agent


8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (dcp-la) has an action to promote synthesis and regeneration of elastin, and is useful as an agent for the prophylaxis or improvement of wrinkles, and an anti-aging drug.. .
Nishizaki Bioinformation Research Institute


02/04/16
20160030521 

Therapeutic agents comprising elastin-like peptides


The present invention provides therapeutic agents and compositions comprising elastin-like peptides (elps) and therapeutic proteins. In some embodiments, the therapeutic protein is a glp-1 receptor agonist, insulin, or factor vii/viia, including functional analogs.
Duke University


01/21/16
20160017004 

Methods and therapeutics comprising ligand-targeted elps


Disclosed herein are novel methods and compositions for targeting drug delivery systems to specific cells. One aspect relates to a drug delivery system comprising an elastin-like peptide (elp) component and a ligand selected from the group consisting of miga and knob capable of either drug encapsulation or drug attachment.
University Of Southern California


12/31/15
20150376806 

Electrochemical processing of materials, methods and production


Electrochemically aligned and compacted molecules, nanoparticles and microparticles with ampholytic nature, such as collagen, elastin, keratin and charged nanoparticle materials, methods of making and using the materials and associated production-related devices. In one embodiment, a device for producing continuous electrochemically aligned strands, threads or fibers is disclosed.
Case Western Reserve University


12/17/15
20150359929 

Mechanochemical collagen assembly


Methods and devices are described for using a controlled extensional strain to organize prefibrillar collagen and/or elastin solutions into an organized array of fibrils. The organized array of collagen fibrils produced by the disclosed methods and devices can be used for tissue engineering applications..
Northeastern University


12/17/15
20150359854 

Insulin receptor induced elastin production


Compositions and methods for modulating the deposition of elastin by administering compositions including insulin receptor agonists are described herein.. .
Human Matrix Sciences, Llc


12/10/15
20150355193 

Methods of validating candidate compounds for use in treating copd and other diseases


The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (copd), chronic bronchitis, emphysema, refractory asthma, and other related diseases.
The Trustees Of Columbia University In The City Of New York


11/12/15
20150322114 

Self-assembling peptides


There is provided a composition comprising a self-assembling membrane, wherein the self-assembling membrane comprises elastin-like polymers (elps) and peptide amphiphiles (pas). Also provided is a method of forming a membrane and uses of the membrane..
Queen Mary University Of London


11/05/15
20150313950 

Use of cellular extracts for skin rejuvenation


The invention describes methods and agents for inducing in the skin one or more effects selected from stimulating fibroblast migration, stimulating elastin production, reducing expression of inflammatory factors and upregulating specific genes, thereby preventing skin cell aging processes and repairing skin damage. In preferred embodiments, the methods and agents comprise active extracts produced from fish eggs..
Regenics As


10/29/15
20150307546 

Thermo-responsive lectin-elp fusion binding ligands for glycoprotein purification by affinity precipitation


The invention provides novel affinity fusion ligands, and method of use thereof, for glycoprotein purification by affinity precipitation. The affinity fusion ligand of the invention comprises a bacterial lectin, e.g., from ralstonia solanacearum (rsl) that binds to fucose, and/or from the vibrio cholera neuraminidase (vcna) that binds to saialic acid, fused with a thermo-responsive polypeptide, e.g., an elastin-like polypeptides (elp) repeats.
Georgia Tech Research Corporation


09/24/15
20150265847 

More dermal retraction with intersecting electromagnetic radiation pathways


A method and device for stimulating human dermal tissue retraction and collagen and elastin production is provided. One or more lasers or other electromagnetic radiation devices produce at least two output beams (split or independent beams) that can be directed to deliver electromagnetic energy to a desired subsurface depth of dermal tissue, thereby disrupting the same, without causing excessive damage to the adjacent epidermis, subcutaneous fatty tissue, or blood vessels of the skin..

08/27/15
20150238431 

Icam-1 targeting elps


Provided herein are therapeutic agents comprising an elastin-like peptide (elp) component and a ligand that specifically targets and binds an icam-1 receptor. In one aspect, the elp comprises, or alternatively consists essentially of, or yet further consists of one or more sequence(s) designated s48i48 and/or micma-1 si and/or hicam-1 s1 or biological equivalents thereof.
University Of Southern California


08/13/15
20150224116 

Combination of azelastine and fluticasone for nasal administration


A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.. .
Cipla Limited


08/06/15
20150218280 

Cd20 scfv-elps methods and therapeutics


Disclosed herein are recombinant polypeptides comprising an elastin-like peptide (elp) and a scfv, or a biological equivalent of the scfv. Also disclosed are compositions containing scfv-elp polypeptides and methods of use..
University Of Southern California


07/16/15
20150196593 

Modulation of zinc levels to improve tissue properties


Methods of altering properties of tissues, by providing an effective modifying amount of zinc, which may be in the form of zinc ions. This is accomplished through the use of topical compositions containing one or more zinc-containing components such as salts and/or other zinc compounds or complexes, particularly zinc acetate.
Precision Dermatology, Inc.


07/09/15
20150190405 

Combination of azelastine and fluticasone for nasal administration


A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.. .
Cipla Limited


06/25/15
20150174425 

Selected light wavelengths and delivery devices for the prevention and treatment of dry eye syndrome


Provided are methods and systems for treating or preventing dry eye syndrome in a subject. The methods involve applying light of a set of photomodulating parameters to the region of the eyelid.

06/18/15
20150164993 

Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases


The present invention relates to a pharmaceutical composition, which contains a mixture of extracts of stemonae radix, asparagi tuber, scutellariae radix, schisandrae fructus, rehmanniae radix preparata, armeniacae semen, and moutan cortex radicis, for suppressing the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating inflammatory bowel diseases, a method for suppressing the expression of inflammatory cytokines by using the composition, and to a food composition, which contains a mixture of extracts of stemonae radix, asparagi tuber, scutellariae radix, schisandrae fructus, rehmanniae radix preparata, armeniacae semen, and moutan cortex radicis, for preventing or ameliorating inflammatory bowel diseases due to cigarette smoke. The pharmaceutical composition, according to the present invention, contains the mixture of extracts of stemonae radix, asparagi tuber, scutellariae radix, schisandrae fructus, rehmanniae radix preparata, armeniacae semen, and moutan cortex radicis, thereby reducing the level of mmp12 expression that is known to destroy il-1β, tnf-α, il-6 and mcp-1, which are inflammatory cytokines that accompany the inflammatory bowel diseases, elastin, and collagen, and thus can be widely used in developing a safe and effective inflammatory bowel disease treating agent..
University-industry Cooperation Group Of Kyung Hee University


06/04/15
20150151028 

Tropoelastin for promoting endothelial cell adhesion or migration


The invention provides methods, compositions, and devices for promoting adhesion or migration of endothelial cell.. .
University Of Utah Research Foundation


06/04/15
20150150934 

Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases comprising stemonae radix extract


The present invention relates to a pharmaceutical composition, which comprises a stemonae radix extract, for preventing or treating the occurrence of inflammatory bowel diseases due to cigarette smoke, a method for preventing or treating the occurrence of inflammatory bowel diseases using the composition, a method for suppressing the expression of inflammatory cytokines using the composition, and to a food composition, which comprises the stemonae radix extract, for preventing or treating the occurrence of inflammatory bowel diseases due to cigarette smoke. The pharmaceutical composition comprising the stemonae radix extract, according to the present invention, reduces the level of mmp12 expression that is known to destroy il-1β, tnf-α, and il-6, which are inflammatory cytokines that accompany the inflammatory bowel diseases, and elastin and collagen, and can suppress decrease in the number of lactobacilli in the intestine, and thus can be widely used in developing a safe and effective inflammatory bowel diseases treating agent..
University-industry Cooperation Group Of Kyung Hee University


04/23/15
20150112330 

Method and vascular tissue sealing with reduced energy consumption


An end effector assembly for use with an electrosurgical instrument is provided. The end effector assembly includes a pair of opposing jaw members configured to grasp tissue therebetween.
Covidien Lp


04/23/15
20150110755 

Elastin producing fibroblast formulations and methods of using the same


The present invention describes therapeutic compositions comprising fibroblasts that have been stimulated to increase expression of extracellular matrix components or elastin, or to produce enhanced elastogenesis or the appearance thereof at a site of administration. The therapeutic fibroblast formulations can be prepared using a variety of elastogenic agents, including digests of mammalian elastin, chemically digested plant extracts comprising elastin-like peptides, and synthetic elastogenic peptides.
The Hospital For Sick Children


04/02/15
20150094465 

N-alkoxyamide conjugates as imaging agents


The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided.
Lantheus Medical Imaging, Inc.


03/19/15
20150078997 

N-alkoxyamide conjugates as imaging agents


The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided.
Lantheus Medical Imaging, Inc.


03/12/15
20150072010 

Combination of azelastine and mometasone for nasal administration


A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.. .
Cipla Limited


03/05/15
20150064292 

Compositions comprising an nfkb-inhibitor and a tropoelastin promoter


The present invention relates to a composition comprising an nfκb-inhibitor and a tropoelastin promoter, and methods of treating signs of skin aging using said compositions.. .
Johnson & Johnson Consumer Companies, Inc.


02/05/15
20150037382 

Microsphere skin treatment


This application provides a microsphere suitable for tissue engineering that comprises connective tissue growth factor (ctgf). Also provided is a matrix, material or scaffold suitable for tissue engineering that comprises connective tissue growth factor (ctgf) and basic fibroblast growth factor (bfgf).
The Trustees Of Columbia University In The City Of New York


01/29/15
20150031633 

Bifunctional peptide


The bifunctional peptide is capable of activating collagen synthesis and inhibiting the production of matrix metallo-proteinases. The peptide has a sequence including three peptide parts a, b and c.
Centre National De La Recherche Scientifique


01/01/15
20150005744 

Devices for the treatment of vascular aneurysm


Devices for the treatment of vascular aneurysms are described. The treatment is achieved through the delivery of an effective amount of elastin stabilization agent to an isolated volume at the aneurysm.
Vatrix Medical, Inc.


01/01/15
20150004184 

Elastin digest compositions and methods utilizing same


The present invention provides compositions for the therapeutic and/or cosmetic treatment of elastin comprising tissues. Therapeutic and cosmetic compositions comprising an elastin digest stimulate the endogenous production of elastin and appear to enhance the elasticity of the skin and provide an external supply of peptide precursors of elastin that penetrate into the tissue to which it is applied.
Human Matrix Sciences, Llc


12/11/14
20140364371 

Direct drug delivery system based on thermally responsive biopolymers


A method for delivering a drug depot of a compound of interest to a selected region in a subject. The method comprises administering a composition directly to said region of interest, the composition comprising the compound of interest to be delivered (such as an antiinflammatory agent or a chemotherapeutic agent) and a polymer (such as an elastin-like peptide or elp) that undergoes an inverse temperature phase transition, so that a sustained release of the compound of interest at the selected region is provided.

12/11/14
20140363563 

Elastin-based copolymers


A copolymer comprising a block of an elastin pentapeptide and method of making and using the copolymer are provided.. .

12/04/14
20140356519 

Elastin-based copolymers and using


A copolymer comprising a block of an elastin pentapeptide and method of making and using the copolymer are provided.. .

12/04/14
20140356323 

Compositions and methods for soft tissue augmentation


The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kda. The present invention further provides methods and kits for soft tissue augmentation..

11/27/14
20140348894 

Engineered protein coating for medical implants


Engineered protein coatings are provided for medical implants to promote bone regeneration. The coating is an engineered protein containing an elastin-like structural domain (seq id no: 2) and a cell-adhesive domain derived from an extended fibronectin rgd sequence.

09/18/14
20140268168 

Apparatus and methods for optical coherence tomography and two-photon luminescence imaging


Exemplary embodiments of the present disclosure include a combined catheter-based optical coherence tomography-two-photon luminescence (oct-tpl) imaging system. Exemplary embodiments further include methods to detect, and further characterize the distribution of cellular components (e.g., macrophage, collagen/elastin fiber, lipid droplet) in thin-cap fibroatheromas with high spatial resolution in vivo..

09/11/14
20140255953 

Granzyme a and granzyme b diagnostics


A method for identifying a subject being at risk for or having a chronic inflammatory disease, fibrillinopathy, atherosclerosis, or coronary artery disease is provided. The method may include determining the concentration of gra and/or grb in a blood or serum sample from said subject; and comparing the concentrations to the corresponding concentration in a control sample, wherein an elevated concentration of gra and/or grb may be indicative of a chronic inflammatory disease, fibrillinopathy, atherosclerosis, or coronary artery disease.

08/21/14
20140235547 

In vivo synthesis of elastic fiber


Disclosed herein are methods of restoring elasticity in tissue using tropoelastin containing compositions.. .

08/07/14
20140220155 

Vaginal tissue rejuvenation compositions and methods


A method of stimulating elastin and/or collagen production in the tissues of the vagina, comprising the steps of providing a composition including at least one of a water soluble zinc salt such as zinc sulfate and a peroxisome proliferator-activated receptor beta/delta (ppar 13/8) agonist, and administering the composition to the tissue of the vagina. Compositions for stimulating 5 elastin and/or collagen production in the tissues of the vagina are also disclosed..

08/07/14
20140220045 

Compositions of a peptide targeting system for treating cancer


This invention describes a protein nanoparticle system for targeting sirna or other drugs into tumors. The basis of the protein system is elastin-like peptides that self-assemble once exposed to the nucleic acid of the sirna.

07/10/14
20140194370 

Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer


A chemoembolic agent is disclosed that includes an injectable, recombinantly synthesized silk-elastin like protein copolymer and one or more chemotherapeutic agents. Upon injection, the chemoembolic agent blocks the tumor vasculature, including the capillary bed, and may optionally release chemotherapeutic agents.

07/10/14
20140193477 

Collagen based materials and uses related thereto


This disclosure relates to materials fabricated from collagen and uses relates thereto. Typically, layers of collagen are stretched during a curing period and optionally coated or impregnated with an elastin like protein.

06/12/14
20140158117 

Compositions comprising azelastine and methods of use thereof


The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions, into the oral cavity, upon intranasal or ocular administration of the compositions.

06/05/14
20140155335 

Elastin protective polyphenolics and methods of using the same


Dermal fibroblasts permanently loose their ability to synthesize elastin, the major component of elastic fibers, shortly after puberty. This progressive loss of elastic fibers cannot be replaced, resulting in the physical signs of aging.

04/17/14
20140106001 

Marine extract compositions and methods of use


Compositions comprising extracts from marine organisms show beneficial effects on skin ailments. Fine lines, wrinkles, and sagging in skin are improved with the application of compositions with marine extracts.

04/10/14
20140100170 

Plant-derived elastin binding protein ligands and methods of using the same


The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of gxxpg (seq id no.

03/06/14
20140065069 

Materials and methods relating to cardiovascular imaging


The invention provides conjugates for imaging plaques, such as cardiovascular plaques, as well as associated pharmaceutical compositions. Other aspects of the invention include methods for administering and imaging such conjugates and compositions, and using the imaging to characterise plaques.

02/27/14
20140056916 

Aldosterone induced vascular elastin production


Compositions and methods for inducing the deposition of elastin by administering compositions including a mineralocorticoid, such as, for example, aldosterone and, optionally, a secondary active agent for enhancing or modulating the effect of the mineralocorticoid are described herein.. .

01/30/14
20140030236 

Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells


Embryonic vascular smooth muscle cells (vsmcs) have a synthetic phenotype (syn-vsmc), but in adults, they commit to the mature contractile phenotype (con-vsmc). Con-vsmcs differ from syn-vsmc derivatives in condensed morphology, prominent filamentous cytoskeleton proteins, elastin production and assembly elastin, low proliferation, numerous active caveolae, enlarged endoplasmic reticulum, ample stress fibers and bundles, as well as high contractility.

01/16/14
20140018909 

Treatment to render implants resistant to diabetes


Disclosed is a medical device treated with a phenolic compound and a process for treating a device with the phenolic compound. For example, a collagen or elastin-based scaffold can be treated with pentagalloyl glucose (pgg).

01/16/14
20140017263 

Delivery agents for targeted treatment of elastin degradation


Methods and delivery agents for treatment of connective tissue that includes elastic fibers are described. Delivery agents are nano- or micro-sized particles that include a biologically active compound useful in treatment of degraded elastic fibers and an anchoring agent at a surface that binds at or near the area of degraded elastic fibers.

12/19/13
20130338221 

Photoaging protective composition containing chromenes derived from sargassum horneri


There is provided a photoaging protective composition having an effect of protecting photoaging on skin cell, the composition including chromenes derived from sargassum horneri. Specifically, for the photoaging protective composition, sargachromanol d and sargachromanol e isolated from sargassum horneri, brown algae exhibits activity of inhibiting mmps, increase an expression of a collagen synthetic marker, such as procollagen and type i collagen in fibroblasts treated with uv-a, or increases elastin by controlling elastase.

12/19/13
20130338089 

Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells


This invention provides methods, processes, compounds and compositions for modulating the gene expression or secretion of adhesion proteins, angiopoietins or their receptors to cure diseases, for anti-angiogenesis and for treating parasites, wherein the adhesion proteins or receptors comprise fibronectin, integrins family, myosin, vitronectin, collagen, laminin, glycosylation cell surface proteins, polyglycans, cadherin, heparin, tenascin, cd 54, cam, elastin and fak; wherein the angiopoietins comprise angiopoietin 1, angiopoietin 2, angiopoietin 3, angiopoietin 4, angiopoietin 5, angiopoietin 6, angiopoietin 7, angiopoietin-like 1, angiopoietin-like 2, angiopoietin-like 3, angiopoietin-like 4, angiopoietin-like 5, angiopoietin-like 6, and angiopoietin-like 7; wherein the cancers comprise breast cancer, leukocyte cancer, liver cancer, ovarian cancer, bladder cancer, prostate cancer, skin cancer, bone cancer, brain cancer, leukemia cancer, lung cancer, colon cancer, cns cancer, melanoma cancer, renal cancer, cervical cancer, esophageal cancer, testicular cancer, spleenic cancer, kidney cancer, lymphatic cancer, pancreas cancer, stomach cancer and thyroid cancer.. .

12/05/13
20130323749 

Granzyme a and granzyme b diagnostics


A method for identifying a subject being at risk for or having a chronic inflammatory disease, fibrillinopathy, atherosclerosis, or coronary artery disease is provided. The method may include determining the concentration of gra and/or grb in a blood or serum sample from said subject; and comparing the concentrations to the corresponding concentration in a control sample, wherein an elevated concentration of gra and/or grb may be indicative of a chronic inflammatory disease, fibrillinopathy, atherosclerosis, or coronary artery disease.

11/28/13
20130315822 

N-alkoxyamide conjugates as imaging agents


The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided.

11/21/13
20130310538 

Methods and compositions for delivering active agents with enhanced pharmacological properties


Provided herein are methods of enhancing in vivo efficacy of an active agent, comprising: administering to a subject an active agent that is coupled to a bioelastic polymer or elastin-like peptide, wherein the in vivo efficacy of the active agent is enhanced as compared to the same active agent when administered to the subject not coupled to (or not associated with) a bioelastic polymer or elp.. .

11/21/13
20130309332 

New use of an extract of plant origin of globularia and obtaining said extract by in vitro plant culture


According to the present invention the extract of plant origin of the globularia genus is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is globularia cordifolia and the extract is obtained by in vitro plant culture.

11/07/13
20130296528 

Preparation and/or formulation of proteins cross-linked with polysaccharides


Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative.

11/07/13
20130295122 

Elastin digest compositions and methods utilizing same


The present invention provides compositions for the therapeutic and/or cosmetic treatment of elastin comprising tissues. Therapeutic and cosmetic compositions comprising an elastin digest stimulate the endogenous production of elastin and appear to enhance the elasticity of the skin and provide an external supply of peptide precursors of elastin that penetrate into the tissue to which it is applied.

11/07/13
20130295117 

Aldosterone induced elastin production


Compositions and methods for inducing the deposition of elastin in skin by administering compositions including a mineralocorticoid, such as, for example, aldosterone and, optionally, a secondary active agent for enhancing or modulating the effect of the mineralocorticoid are described herein.. .

10/24/13
20130280782 

Protein-based conjugates and self-assembled nanostructures


The present disclosure provides protein-containing compositions, methods and uses thereof. A conjugate comprises a globular protein conjugated with a polymer that preserves the folded and functional structure of a protein.

10/17/13
20130273586 

Methods of validating candidate compounds for use in treating copd and other diseases


The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (copd), chronic bronchitis, emphysema, refractory asthma, and other related diseases.

10/17/13
20130273580 

Elisa assay kit, elisa for determining desmosine levels from urine samples and diagnostic urine assays for aneurysms


Improved elisa assay formats are described that provide for effective measurement of desmosine, an elastin degradation product, in urine samples. The urine samples can be effectively introduced into the assay with little or no sample preparation.

10/03/13
20130259915 

Method for the treatment of skin


A composition for the treatment of skin comprises a non-emulsified, aqueous suspension of retinol. The composition may further include at least one protein species, and some proteins used in the composition include collagen and elastin.

09/26/13
20130253429 

Medical devices to facilitate tissue stabilization for heart failure


Methods and devices for the stabilization of heart tissue to treat congestive heart failure using a therapeutic composition are discussed. The therapeutic composition can comprise an elastin stabilization agent, a collagen stabilization agent, or a combination thereof and be applied to the pericardium, to the outer surface of the myocardium, or a combination thereof using a catheter type of device with an attached reservoir.

09/26/13
20130253053 

Method of treating skin with microrna modulators


Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents that suppress or down-regulate microrna expression in dermal fibroblast, resulting in enhanced production of collagen, elastin and/or fibrillin in the skin. Also provided are methods for screening for activity against specific micrornas and the methods of using active agents identified by the screening protocol in the treatment of skin..

09/26/13
20130252929 

Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration


The present invention provides a pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride, wherein the pharmaceutical composition comprises thaumatin as an agent for reducing bitterness and irritation.. .

09/19/13
20130245750 

Biomaterials with enhanced properties and devices made therefrom


Biomaterials with enhanced properties such as improved strength, flexibility, durability and reduced thickness are useful in the fabrication of biomedical devices, particularly those subjected to continuous or non-continuous loads where repeated flexibility and long-term durability are required. These enhanced properties can be attributed to elevated levels of elastin, altered collagen types, and other biochemical changes which contribute to these enhanced properties.

09/19/13
20130245616 

Method for picosecond and femtosecond laser tissue welding


A method for welding tissue wounds in an animal. The method comprises joining edges of a tissue wound and irradiating the tissue wound and tissue surrounding the tissue wound with a pulsed laser.

08/15/13
20130210747 

Methods and therapeutics comprising ligand-targeted elps


Disclosed herein are novel methods and compositions for targeting drug delivery systems to specific cells. One aspect relates to a drug delivery system comprising an elastin-like peptide (elp) component and a ligand selected from the group consisting of miga and knob capable of either drug encapsulation or drug attachment.

08/01/13
20130197359 

Solid lipid nanoparticles including elastin-like polypeptides and use thereof


Solid lipid nanoparticles (slns) including elastin-like polypeptides, compositions comprising the slns, and uses thereof are provided.. .

08/01/13
20130197102 

3d matrices of human elastin-like polipeptides and preparation thereof


3d matrices or hydrogels made of human elastin-like polypeptides and their preparation are described. Said matrices can be obtained by enzymatic cross-linking of such polypeptides and can be used in the biomedical and pharmaceutical fields as support the growth of cells, isolated or as multicellular association, both on the surface and inside the matrix.

07/18/13
20130184199 

Insulin receptor induced elastin production


Compositions and methods for modulating the deposition of elastin by administering compositions including insulin receptor agonists are described herein.. .

07/11/13
20130178416 

Fusion peptide therapeutic compositions


Therapeutic compositions containing fusion proteins (fps) including elastin-like peptides (elps) and peptide active therapeutic agents, and methods of making and using such compositions and fusion proteins. Therapeutic compositions of such type enable improved efficacy of the peptide active therapeutic agent to be achieved, in relation to the peptide active therapeutic agent alone.

07/04/13
20130172274 

Methods and compositions for delivering active agents with enhanced pharmacological properties


Provided herein are methods of enhancing in vivo efficacy of an active agent, comprising: administering to a subject an active agent that is coupled to a bioelastic polymer or elastin-like peptide, wherein the in vivo efficacy of the active agent is enhanced as compared to the same active agent when administered to the subject not coupled to (or not associated with) a bioelastic polymer or elp.. .



Elastin topics: Mometasone Furoate, Medical Device, Polypeptide, Azelastine, Antibodies, Aortic Aneurysm, Polyclonal, Sample Preparation, Control Group, Refractory, Spectrometry, Internal Standard, Elastic Fiber, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Elastin for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Elastin with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.6115

4360

0 - 1 - 101